Latanoprost is an ophthalmic solution used for the treatment of glaucoma. Carl B Camras and Laszlo Z Boti share the credit of bringing this medicine into the market in 1996. It is manufactured by a pharmaceutical company named Pfizer. It was approved by FDA in March 22, 2011.